The Worldwide Artificial Intelligence in Diabetes Management Industry is Expected to Reach $2.2 Billion by 2027 - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--Oct 4, 2022--

The "Global Artificial Intelligence in Diabetes Management Market (2022-2027) by Device, Technique, and Geography, with Competitive Analysis, Impact of COVID-19, and Ansoff Analysis" report has been added to ResearchAndMarkets.com's offering.

The Global Artificial Intelligence in Diabetes Management Market is estimated to be worth USD 590.32 million in 2022, and is expected to reach USD 2,235.15 million by 2027, growing at a CAGR of 30.51%.

Market dynamics are forces that impact the prices and behaviors of the stakeholders. These forces create pricing signals which result from the changes in the supply and demand curves for a given product or service. Forces of Market Dynamics may be related to macro-economic and micro-economic factors.

There are dynamic market forces other than price, demand, and supply. Human emotions can also drive decisions, influence the market, and create price signals. As the market dynamics impact the supply and demand curves, decision-makers aim to determine the best way to use various financial tools to stem various strategies for speeding the growth and reducing the risks.

The Competitive Quadrant

The report includes the Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc.

Ansoff Analysis

• The report presents a detailed Ansoff matrix analysis for the Global Artificial Intelligence in Diabetes Management Market. Ansoff Matrix, also known as Product/Market Expansion Grid, is a strategic tool used to design strategies for the growth of the company. The matrix can be used to evaluate approaches in four strategies viz. Market Development, Market Penetration, Product Development and Diversification. The matrix is also used for risk analysis to understand the risk involved with each approach.
• The Global Artificial Intelligence in Diabetes Management Market is analyzed using the Ansoff Matrix to provide the best approaches a company can take to improve its market position.
• Based on the SWOT analysis conducted on the industry and industry players, suitable strategies have been devised for market growth.

Why Buy This Report?

• The report offers a comprehensive evaluation of the Global Artificial Intelligence in Diabetes Management Market. The report includes in-depth qualitative analysis, verifiable data from authentic sources, and projections about market size. The projections are calculated using proven research methodologies.
• The report has been compiled through extensive primary and secondary research. The primary research is done through interviews, surveys, and observation of renowned personnel within the industry.
• The report includes an in-depth market analysis using Porter's 5 forces model and the Ansoff Matrix. In addition, the impact of COVID-19 on the market is also featured in the report.
• The report also includes the regulatory scenario within the industry, which will help you make a well-informed decision. The report discusses major regulatory bodies and major rules & regulations imposed on this sector across various geographies.
• The report also contains competitive analysis using 'Positioning Quadrants'; a proprietary competitive positioning tool.

Market Dynamics

Drivers

• Increasing Demand for Smart Glucose Monitoring Device
• Rising Geriatric Population and Unhealthy Lifestyle
• Increasing Prevalence of Type 2 Diabetes Patients

Restraints

• Expensive AI-based Medical Devices

Opportunities

• Increasing Mobile Apps to Monitor and Manage Diabetes
• Inclination Towards the Home Care or Self-management of Diabetes

Challenges

• Lack of Awareness in Emerging Countries

Market Segmentation

The Global Artificial Intelligence in Diabetes Management Market is segmented based on Device, Technique, and Geography.

• By Device, the market is classified into Diagnostic Devices, Glucose Monitoring Devices, and Insulin Delivery Devices.
• By Technique, the market is classified into Case-based Reasoning and Intelligent Data Analysis.
• By Geography, the market is classified into Americas, Europe, Middle-East & Africa, and Asia-Pacific.

Companies Mentioned

• Abbott Laboratories
• Apple Inc.
• Bigfoot Biomedical, Inc.
• Cardinal Health Inc.
• Crayon Group
• DreaMed Diabetes, Ltd.
• Eyenuk, Inc.
• Glooko SAS
• Google Inc.
• HCL Technologies Ltd.
• IBM Corp.
• Medtronic PLC
• Nasdaq Inc.
• Novo Nordisk A/S
• Roche Holding AG
• Sanofi SA
• Virta Health Corp.
• Vodafone Group PLC
• Wellthy Therapeutics Pvt. Ltd.
• xbird GmbH

For more information about this report visit https://www.researchandmarkets.com/r/33g9eg

View source version on businesswire.com:https://www.businesswire.com/news/home/20221004005673/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./ CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

KEYWORD:

INDUSTRY KEYWORD: TECHNOLOGY DIABETES HEALTH ARTIFICIAL INTELLIGENCE

SOURCE: Research and Markets

Copyright Business Wire 2022.